Relationship between gut microbiota and type 2 diabetic erectile dysfunction in Sprague-Dawley rats

Abstract

In order to investigate the relationship between gut microbiota and type 2 diabetic erectile dysfunction (T2DED), we analyzed the characteristics of gut microbiota in the Sprague-Dawley (SD) rats with T2DED. Thirty-five SD rats were randomly divided into two groups: control group (n=15) with normal diet, and experimental group (n=20) with construction of T2D model. Faecal and serum samples were collected at 2nd and 8th week after establishment of T2D model, respectively. Faecal samples were used for analysis of gut microbiota, and serum samples for detection of trimethylamine N-oxide (TMAO), lipopolysaccharide (LPS), and inflammatory factors like interleukin-1 (IL-1), IL-2, IL-10, and monocyte chemoattractantprotein-1 (MCP-1). The main compositions of gut microbiota were Bacteroidetes, Proteobacteria and Firmicutes at the phylum level, and Oscillospira, Allobaculum, Bacteroides, Ruminococcus, SMB53, Prevotella, Coprococcus, Sutterella and Blautia at the genus level with relatively higher abundance in all SD rats. The relative abundance of Enterococcus, Corynebacterium, Aerococcus, Facklamia (opportunistic pathogens in most case) increased, and that of Allobaculum, Bifidobacterium, Eubacterium, Anaerotruncus (beneficial bacteria) decreased in T2DED group as compared with that at 2nd week after establishment of T2D model (T2D2 group). The serum contents of TMAO, LPS, IL-1, IL-2, IL-10 and MCP-1 in T2DED group were significantly higher than those in control group. The gut microbiota of T2DED rats was inhibited. The gut microbiota of T2DED rats had changed, as the relative abundance of beneficial bacterium was decreased while that of opportunistic pathogens was increased. The variations of gut microbiota might lead to inflammation and prompt the emergence of erectile dysfunction in the rats with T2D. TMAO might play an important role in the formation of T2DED.

Keywords

gut microbiota / erectile dysfunction / type 2 diabetes mellitus

References

[1] PanF, YouJ, LiuY, et al. . Differentially expressed microRNAs in the corpus cavernosum from a murine model with type 2 diabetes mellitus-associated erectile dysfunction. Mol Genet Genomics, 2016, 291(6): 2215-2224 PMID: 27681254

[2] YohannesE, ChangJ, TarMT, et al. . Molecular targets for diabetes mellitus-associated erectile dysfunction. Mol Cell Proteomics, 2010, 9(3): 565-578 PMID: 20007950

[3] VilasecaA, MusqueraM, NguyenDP, et al. . Changing patterns in the surgical management of renal masses. Actas Urol Esp, 2016, 40(3): 148-154 PMID: 26687094

[4] ScullyT. Diabetes in numbers. Nature, 2012, 485(7398): S2-S3 PMID: 22616094

[5] YadavH, JainS, SinhaPR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition, 2007, 23(1): 62-68 PMID: 17084593

[6] EjtahedHS, Mohtadi-NiaJ, Homayouni-RadA, et al. . Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition, 2012, 28(5): 539-543 PMID: 22129852

[7] PriyadarshiniM, WicksteedB, SchiltzGE, et al. . SCFA receptors in pancreatic beta cells: novel diabetes targets?. Trends Endocrinol Metab, 2016, 27(9): 653-664 PMID: 27091493

[8] QinJ, LiY, CaiZ, et al. . A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 2012, 490(7418): 55-60 PMID: 23023125

[9] ChenL, MaglianoDJ, ZimmetPZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol, 2012, 8(4): 228-236

[10] ManichanhC, Rigottier-GoisL, BonnaudE, et al. . Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut, 2006, 55(2): 205-211 PMID: 16188921 PMCID: 1856500

[11] CaporasoJG, LauberCL, WaltersWA, et al. . Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA, 2011, 108: 4516-4522 PMID: 20534432

[12] CaporasoJG, LauberCL, WaltersWA, et al. . Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J, 2012, 6(8): 1621-1624 PMID: 22402401 PMCID: 3400413

[13] YinJ, LiaoSX, HeY, et al. . Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc, 2015, 4(11): 2699

[14] ForestaC, CarettaN, LanaA, et al. . Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res, 2005, 17(3): 288-290 PMID: 15729373

[15] GuayAT. ED2: erectile dysfunction = endothelial dysfunction. Endocrinol Metab Clin North Am, 2007, 36(2): 453-463 PMID: 17543729

[16] ChenK, ZhengX, FengM, et al. . Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in western diet-induced obese mice. Front Physiol, 2017, 8: 139 PMID: 28377725 PMCID: 5359299

[17] WangZ, KlipfellE, BennettBJ, et al. . Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 2011, 472(7341): 57-63 PMID: 21475195 PMCID: 3086762

[18] UssherJR, LopaschukGD, ArduiniA. Gut microbiota metabolism of L-carnitine and cardiovascular risk. Atherosclerosis, 2013, 231(2): 456-461 PMID: 24267266

[19] Cho CE, Taesuwan S, Malysheva OV, et al. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial. Mol Nutr Food Res, 2017,61(1). doi: 10.1002/mnfr.201600324.

[20] TangWH, HazenSL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest, 2014, 124(10): 4204-4211 PMID: 25271725 PMCID: 4215189

[21] KoethRA, WangZ, LevisonBS, et al. . Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med, 2013, 19(5): 576-585 PMID: 23563705 PMCID: 3650111

[22] ZhuW, GregoryJC, OrgE, et al. . Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell, 2016, 165(1): 111-124 PMID: 26972052 PMCID: 4862743

[23] SeldinMM, MengY Q, et al. . Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-B. J Am Heart Assoc, 2016, 5(2): e2767

[24] SunX, JiaoX, MaY, et al. . Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIPNLRP3 inflammasome. Biochem Biophys Res Commun, 2016, 481(1-2): 63-70 PMID: 27833015

[25] MaG, PanB, ChenY, et al. . Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion. Biosci Rep, 2017, 37(2): BSR20160244 PMID: 28153917 PMCID: 5333780

[26] MantzouranisG, FaflioraE, GlanztounisG, et al. . Inflammatory bowel disease and sexual function in male and female patients: an update on evidence in the past ten years. J Crohns Colitis, 2015, 9(12): 1160-1168 PMID: 26254470

[27] LeeJH, LeeJS, ParkJY, et al. . Association of lifestyle-related comorbidities with periodontitis: a nationwide cohort study in Korea. Medicine (Baltimore), 2015, 94(37): e1567

[28] WimalawansaSJ. Nitric oxide and bone. Ann N Y Acad Sci, 2010, 1192: 391-403 PMID: 20392265

[29] ZhangX, VallabhaneniR, LoughranPA, et al. . Changes in FADD levels, distribution, and phosphorylation in TNFalpha-induced apoptosis in hepatocytes is caspase-3, caspase-8 and BID dependent. Apoptosis, 2008, 13(8): 983-992 PMID: 18543108

[30] HeWQ, QiaoYN, PengYJ, et al. . Altered contractile phenotypes of intestinal smooth muscle in mice deficient in myosin phosphatase target subunit 1. Gastroenterology, 2013, 144(7): 1456-1465 PMID: 23499953 PMCID: 3782749

[31] QiaoYN, HeWQ, ChenCP, et al. . Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure. J Biol Chem, 2014, 289(32): 22512-22523 PMID: 24951589 PMCID: 4139257

[32] ShenW, ShenM, ZhaoX, et al. . Anti-obesity effect of capsaicin in mice fed with high-fat diet is associated with an increase in population of the gut bacterium Akkermansia muciniphila. Front Microbiol, 2017, 8: 272 PMID: 28280490 PMCID: 5322252